| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Gravier Pierre is a Chief Financial Officer at PTC THERAPEUTICS, INC.. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $6.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 2,139 | $76.95 | $164,596.05 | -2.3% | -10.2% | - | |
| Jul 15, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 2,516 | $49.46 | $124,441.36 | -3.4% | +38.3% | - | |
| Feb 20, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 2,335 | $50.11 | $117,006.84 | -1.5% | -8.3% | +40.3% | |
| Jul 16, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 2,269 | $34.02 | $77,200.46 | -4.1% | +14.5% | +40.9% | |
| Dec 12, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Buy | 7,700 | $25.81 | $198,736.23 | +29.6% | +17.6% | +90.2% |